Work by the ENCODE consortium and others has helped to characterise a wide catalogue of regulatory elements, also referred to as enhancers, that control developmental gene expression in many species^[@R3]--[@R5]^. One of the most intriguing characteristics of these elements is their tendency to arrange in clusters, displaying redundancy in reporter assays and similarities in transcription factor occupancy^[@R6],[@R7]^. Previous studies in *Drosophila* revealed that the observed redundancy may provide the system with robustness and spatio-temporal precision^[@R8]--[@R10]^. However, how the complex patterns of gene expression during development are achieved and why this involves elements with apparently redundant/overlapping function remains elusive. Copy number variations (CNVs) generally include non-coding regions of the genome and can thus interfere with the composition and dosage of regulatory elements, but the effects of such alterations are poorly understood.

We investigated the effects of deletions and duplications upstream of *Indian Hedgehog* (*IHH*), a master gene of skeletal development involved in chondrocyte differentiation, joint formation and osteoblast differentiation. Accordingly, *Ihh* inactivation in mice results in extreme shortening of bones, joint fusions and almost absent ossification, ultimately causing early lethality^[@R11]^. Interestingly, patients carrying duplications at this locus display completely different phenotypes including craniosynostosis, syndactyly, and polydactyly^[@R1],[@R2]^, indicating alternative pathomechanisms. To define the regulatory landscape of *Ihh*, we performed 4C-seq in E14.5 developing limbs and compared them to published datasets^[@R12]^. Our data show that the *Ihh* promoter interacts preferentially with the third intron of its upstream neighbouring gene, *Nhej1* ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}), a genomic region affected in all reported disease-associated duplications. The region contains multiple sites positive for H3K4me1 and H3K27ac (indicative of active enhancers) and binding sites for CTCF, an architectural protein involved in facilitating enhancer-promoter contact by looping, The convergent CTCF motif orientation observed across the locus might facilitate the interactions measured in 4C-seq experiments ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"})^[@R13]--[@R16]^.

The insertion of a LacZ reporter cassette (sleeping beauty)^[@R17]^ to capture the regulatory capacity of the region revealed a pattern consistent with *Ihh* expression, i.e. condensing digits, growth plates, fingertips and skull sutures. Using a combination of H3K27ac and H3K4me1 ChIP-seq of E14.5 limbs^[@R18]^, conservation^[@R19]^, and our 4C-seq interaction profiles, we defined 9 regions with enhancer potential and validated them in mouse transgenic enhancer activity assays^[@R20]^ ([Fig. 1a](#F1){ref-type="fig"}). Embryos were analyzed at two time points, E14.5 and E17.5, to capture *Ihh* expression domains during digit development (fingertips and cartilage anlagen) and bone growth (skull sutures and growth plates), respectively. 5 of the tested elements showed activity at both stages ([Fig. 1b](#F1){ref-type="fig"}), whereas 4 additional elements were active only at E17.5 ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). We scored the activity of each element in the previously identified regions ([Fig. 1b](#F1){ref-type="fig"}, [Supplementary Fig. 3 and Table 1](#SD1){ref-type="supplementary-material"}). This revealed the inherent complexity of this cluster, where almost every individual element displayed a unique pattern of activity. All elements gave a positive signal in growth plates, whereas other domains, like fingertips, were covered only by a small subset of enhancers (i5 and i7). This suggests that the enhancers in this cluster act in a modular fashion and that the degree of overlapping activity varies between tissues and developmental time points.

To evaluate the functionality of these elements, we deleted intron 3 of *Nhej1* ([Fig. 2](#F2){ref-type="fig"}), which contains 8 of the 9 identified enhancers, using CRISVar^[@R21]^. *Nhej1* encodes a DNA repair protein essential for the nonhomologous end-joining pathway, required for double-strand break repair. In humans, homozygous mutations in *NHEJ1* result in severe combined immunodeficiency (SCID) with microcephaly, growth retardation, and sensitivity to ionizing radiation, reflecting a deficiency in DNA-repair (OMIM \#611291)^[@R22]^. In contrast, *Nhej1* knockout mice are viable and do not display any morphological phenotype^[@R23],[@R24]^. μCT scans of *Nhej1*^−/−^ skulls revealed no abnormalities indicating that *Nhej1* has no major role in skull and suture development ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). Mice homozygous for the *Nhej1* intronic deletion \[Del(2--9)\] displayed very short limbs, absent cortical bone, fused joints, as well as reduced skull ossification, very similar to those observed upon *Ihh* inactivation^[@R11]^. While *Nhej1* transcription levels remained basically unchanged ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}), we observed a drastic reduction of *Ihh* mRNA expression in E13.5 limbs and E17.5 skulls (98% and 99%, respectively), consistent with the observed phenotype. Therefore, this region contains most of the regulatory elements required for *Ihh* skeletal expression.

Next, we generated a series of specific deletions to assess the functional redundancy within this enhancer cluster ([Fig. 2](#F2){ref-type="fig"}). A homozygous deletion of the enhancers located in the telomeric part of the intron \[Del(4--9)\] resulted in a lethal growth defect almost as severe as the deletion of the entire intron confirming that the most relevant enhancers are located in the telomeric region. Deletion of only the three central enhancers \[Del(4--6)\] reduced *Ihh* expression by approx. 70% in all tested tissues, whereas the deletion of the three more telomeric enhancers \[Del(7--9)\] resulted in a 60% reduction ([Fig. 2](#F2){ref-type="fig"}). Both mutants were viable and phenotypically normal, but showed a delay in skull ossification ([Fig. 2](#F2){ref-type="fig"}) and a 10% reduction in bone length ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). All deletions except Del(7--9) resulted in a loss of fingertip expression, indicating that element i5 acts as a major regulator for this region. These results demonstrate that *Ihh* expression is controlled by a cluster of redundant enhancers, which appear to act in an additive manner.

To understand the mechanisms underlying pathogenic duplications at the *IHH* locus, we duplicated the entire *Nhej1* intron, equivalent to Del(2--9)\]. In addition, we re-engineered two of the previously described human duplications: Dup(csp) encompassing the region between enhancers i1--5 (re-engineered human duplication causing craniosynostosis Philadelphia type^[@R1],[@R2]^); and Dup(syn) which includes *Ihh* and the upstream region up to enhancer i5 (re-engineered human duplication causing syndactyly Lueken type^[@R2]^) ([Fig. 3a](#F3){ref-type="fig"}). Dup(int) and Dup(csp) mutants did not show gross morphological alterations. In contrast, Dup(syn)/+ mice showed a complete cutaneous syndactyly of digits 2/5 in fore- and hindlimbs ([Fig. 3b](#F3){ref-type="fig"}), thus recapitulating the human phenotype.

Skeletal stainings revealed that the syndactyly of Dup(syn) mutants did not involve bony fusions. Digits and joints developed normally, but terminal phalanges were broad and short. *In situ* hybridization experiments in E13.5 limbs revealed major changes in fingertips, where *Ihh* expression was not only increased but also broadened. These effects were weak in Dup(csp), more pronounced in Dup(int) and most prominent in Dup(syn)/+ mice, in which *Ihh* expression extended into the distal interdigital space ([Fig. 3c](#F3){ref-type="fig"}). Accordingly, the expression domains of the hedgehog downstream targets *Gli1* and *Ptch1* were broadened and a fusion between the normally separated domains was observed which was most pronounced in Dup(syn)/+ mutants. Except for *Bmp4* and *Nog*, we did not observe abnormalities in other genes/pathways involved in syndactyly/interdigital cell death ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}) suggesting that hedgehog signalling alone is sufficient to induce this type of syndactyly. Next, we quantified interdigital apoptosis, which is required for digit separation^[@R25]^. Consistent with the observed phenotype we observed a strong signal in the interdigital space in wt, Dup(csp) and Dup(int) embryos, but an absence of signal in the distal region in Dup(syn)/+ mice ([Fig. 3d](#F3){ref-type="fig"}). Thus, upregulation and misexpression of *Ihh* in fingertips beyond a certain threshold resulted in abnormalities of the distal phalanges, most likely by interfering with the phalanx-forming region^[@R26]^, and syndactyly due to suppression of interdigital apoptosis.

In addition, Dup(syn) mutants displayed preaxial polydactyly on hindlimbs (50% penetrance, [Fig. 3e](#F3){ref-type="fig"}). One major cause of polydactyly is ectopic activation of hedgehog signalling at the anterior developing limb bud^[@R27],[@R28]^. Interestingly, Dup(syn)/+ mice showed a prominent increase of *Ihh* expression in the distal zeugopod during hindlimb development starting at E12.5 (negative at E10.5/E11.5). As *Ihh* is a potent diffusible morphogen, we hypothesise that the increased expression might interfere with the anterior-posterior Hedgehog gradient. The observed phenotype is thus the result of a loss of precision in spatio-temporal expression levels indicating that, similar to the syndactyly, an increase in enhancer dosage can have site-specific effects.

Expression profiling by qPCR was used to quantify the effect of the duplications on gene expression ([Fig. 3f](#F3){ref-type="fig"}). Whereas *Nhej1* and other nearby genes showed no alteration ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}), all analysed mutants displayed increased *Ihh* expression in skull and limbs, with the highest expression levels observed in Dup(int) (up to 5-fold upregulation). *In situ* hybridization of Dup(int) forelimb autopods ([Fig. 3c](#F3){ref-type="fig"}) showed increased expression mainly in digits, whereas in Dup(syn) mutants the expression increase was most prominent in fingertips, consistent with the observed syndactyly. To investigate the effect of increased *Ihh* expression on skull development and suture formation a detailed μCT analysis was performed ([Fig. 3g](#F3){ref-type="fig"}). This revealed a fusion of the metopic suture (craniosynostosis) in all mutants, but most pronounced in Dup(int) mice. The phenotypes observed in our mouse mutants (i.e. syndactyly, polydactyly, craniosynostosis) accurately recapitulate previous observations in human patients^[@R1],[@R2]^ ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). Thus, the induced changes in changes in enhancer composition and dosage resulted in a disturbance of level and precision of gene expression thereby causing abnormal development and disease. Interestingly, the observed phenotypes did not always correlate with the number of duplicated elements but appeared to be influenced by other factors such as the position of the duplication and the arrangement of individual elements relative to the cluster.

To investigate a possible effect of the spatial configuration on the duplicated alleles, we performed 4C-seq experiments in E14.5 limbs (viewpoint=*Ihh*; [Fig. 4a](#F4){ref-type="fig"}). In Dup(int)/+ mutants (i2--9 enhancer duplication) we observed increased interactions across the entire duplicated region. In contrast, Dup(syn)/+ mutants (*Ihh* and i1--5 enhancer duplication) only showed increased contact with the centromeric region of the enhancer cluster, suggesting that the centromeric *Ihh* copy created an own regulatory domain containing only the duplicated regulatory elements i1--5 ([Fig. 4b](#F4){ref-type="fig"}). The presence of a divergently oriented CTCF pair near the telomeric *Ihh* promoter might explain this domain separation by limiting chromatin interaction beyond this site. Moreover, the larger contact areas in Dup(int)/+ mutants correlate with the observed levels of *Ihh* upregulation compared to Dup(syn)/+. As illustrated in [Fig. 4c](#F4){ref-type="fig"}, the syndactyly in Dup(syn)/+ mice is likely due to two types of interactions of the major fingertip enhancer i5 with the two copies of *Ihh*, one via long range, the other by placing the i5 enhancer in direct proximity to *Ihh.* Together, this results in a localized upregulation of *Ihh* expression in the fingertips. An increased expression mediated by the disconnection from a repressor element is unlikely, as none of the studied deletions resulted in any observable upregulation of *Ihh*. To further evaluate whether the observed limb phenotypes in the *Ihh* containing duplication \[Dup(syn)\] was merely a gene dosage effect, we crossed Dup(syn)/+ mice with *Ihh*^−^*^/+^* mice and with mice lacking the enhancer cluster \[Del(2--9)\]. In both cases, double heterozygous mice displayed the same syndactyly and polydactyly as observed in Dup(syn)/+ mice ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}) indicating that the misexpression was due to the specific, partially duplicated regulatory landscape.

Our study shows that a multipartite enhancer ensemble regulates *Ihh* expression in fingertips, digit condensations, growth plates and skull sutures. The described functional redundancy appears to be a common phenomenon of these types of enhancers, as recently shown for the alpha-globin or the *Wap* super-enhancers^[@R29],[@R30]^. At the *Ihh* locus, we observed a complex scenario as not all enhancers display the same combination of expression domains, a phenomenon also described for the *HoxD* cluster and *Fgf8*^[@R31],[@R32]^. This modular nature and, in particular, the correct dosage appears critical to confer the required precision of gene expression. This is supported by our finding that an increase in enhancer number resulted in an increase in gene expression. However, this effect was site-specific and dependent not only on the enhancer number but also on their position. CNVs, and in particular duplications, may affect this delicate balance, thereby causing over- and/or misexpression resulting in disease. The reported duplications do not interfere with topologically associating domain (TAD) boundaries, as reported at the *Epha4* and *Sox9* loci^[@R33],[@R34]^, thus highlighting alternative mechanisms that should be considered when interpreting genomic duplications. Our study highlights the importance of analysing regulatory elements in the complex setting of their native genomic environment since reductionist approaches relying on reporter assays and deletions of individual enhancers insufficiently capture the multifaceted redundant and complementary functions of enhancer clusters.

ONLINE METHODS {#S1}
==============

No statistical methods were used to predetermine sample size. All experiments and analyses were performed using samples from at least 3 different animals and repeated at least 2 times in the laboratory. Samples/animals were included/excluded according to genotype by PCR. Experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment.

ES cell targeting and transgenic mouse strains {#S2}
----------------------------------------------

Embryonic stem (ES) cell culture was performed as described previously^[@R21]^. ES and feeder cells were tested for mycoplasma contamination using Mycoalert detection kit (Lonza) and Mycoalert assay control set (Lonza).

Duplications and deletions were generated in G4 ES cells (129/Sv × C57BL/6 F1 hybrid) using CRISVar as described previously^[@R21]^. Target regions, sizes and guide sequences are listed in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}. Embryos and live animals from ES cells were generated by diploid or tetraploid complementation^[@R35]^. Genotyping was performed by PCR analysis.

A Sleeping Beauty (SB) cassette^[@R17]^ was inserted in G4 ES cells at the center of the third intron of the *Nhej1* gene (chr1:75,060,87; mm9), by homologous recombination using standard protocols^[@R36]^. The SB transgene carries a single a LacZ reporter gene with a minimal human β-globin promoter and a Neomycin resistance cassette, flanked by transposable elements. Coordinates and primer sequences for amplifying homology sequences are provided in [Supplementary Table 3](#SD1){ref-type="supplementary-material"}. Positive ES cell clones were injected into donor blastocysts to generate chimaeras. Neomycin cassette was removed by crossing chimaeric animals with a Flpe-deleter line. Genotyping was performed by PCR analysis.

Mouse strains were maintained by crossing them with C57BL6/J mice. All animal procedures were conducted as approved by the local authorities (LAGeSo Berlin) under the license numbers G0368/08 and G0247/13.

*In vivo* enhancer validation {#S3}
-----------------------------

Putative enhancer regions were amplified by PCR from mouse genomic DNA and cloned into a Hsp68-promoter-LacZ reporter vector as previously described^[@R20]^ (see [Supplementary Table 4](#SD1){ref-type="supplementary-material"}). Transgenic embryos were generated and tested for LacZ reporter activity at E14.5 and E17.5. All animal work performed at Lawrence Berkeley National Laboratory was reviewed and approved by the institutional Animal Welfare and Research Committee (AWRC). Sample sizes were selected empirically based on our previous experience of performing transgenic mouse assays for \>2,000 total putative enhancers. A summary of all transgenic mice can be found in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. As all transgenic mice were treated with identical experimental conditions, and as there were no groups of animals directly compared in this section of the study, randomization and experimenter blinding were unnecessary and not performed.

Quantitative Real-Time PCR {#S4}
--------------------------

Handplates (E13.5), fore- and hindlimb growth plates (E17.5) and cranium (E17.5) were dissected from wild type and mutant embryos (n≥3) in ice cold PBS/DEPC and immediately frozen in liquid nitrogen. RNA isolation was performed using RNAeasy Kit (Qiagen), and cDNA was transcribed using TaqMan Reverse Transcription Kit (Roche) according to the specification of the manufacturer. qPCR was performed using SYBRGreen (Qiagen) in a ABIPrism HT 7900 Real-time Cycler. GAPDH was used as an internal control, and fold changes were calculated by relative quantification (2^−ΔΔCt^). Primers are summarized in [Supplementary Table 5](#SD1){ref-type="supplementary-material"}.

4C-seq {#S5}
------

4C-seq libraries were generated from microdissected E14.5 mouse forelimb tissue (digit 2--5) as described previously^[@R37]^. The starting material for all 4C-seq libraries was 5×10^6^--1×10^7^ cells. All 4C-seq experiments were carried out in heterozygous animals and compared to wildtype controls. 4-bp cutters were used as primary (Csp6I) and secondary (BfaI) restriction enzymes. A total of 1 to 1.6 μg DNA was amplified by PCR (primer sequence in [Supplementary Table 6](#SD1){ref-type="supplementary-material"}). All samples were sequenced with Illumina Hi-Seq technology according to standard protocols. 4C-seq experiments were carried out in two biological replicates in wild type, Dup(int) and Dup(syn)/+ mutants. A representative result is shown in the [Figure 4](#F4){ref-type="fig"}.

For 4C-seq data analysis, reads were pre-processed, mapped to a corresponding reference (mm9) using BWA-MEM^[@R38]^ and coverage normalized as reported previously^[@R34]^. The viewpoint and adjacent fragments 1.5 kb up and downstream were removed and a window of 2 fragments was chosen to normalize the data per million mapped reads (RPM). To compare interaction profiles of different samples, we obtained the log2 fold change for each window of normalized reads. To obtain ratios duplicated regions were excluded for calculation of the scaling parameter used in RPM normalization. Code is available upon request.

CTCF motif orientation analysis {#S6}
-------------------------------

Orientation of the motifs within conserved CTCF peaks was obtained using FIMO (see URLs) with standard parameters^[@R39]^. CTCF motif^[@R40]^ was obtained from JASPAR database (see URLs).

Phenotypic analysis {#S7}
-------------------

Phenotypic analysis for mutant mouse lines was carried out for at least three animals per analysis and developmental stage (E17.5, P7 and P70), in homo- and heterozygous animals. Penetrance of phenotypes was determined by analyzing n\>20 animals and considered fully penetrant if all mutants were similarly affected.

Micro-computer tomography (μCT) {#S8}
-------------------------------

Skulls and autopods of control and mutant mice (n \> 3) were scanned using a Skyscan 1172 X-ray microtomography system (Brucker microCT, Belgium) at 10μm resolution. 3D model reconstruction and length measurements were performed with the Skyscan image analysis software CT-Analyser and CT-volume (Brucker microCT, Belgium). Cross-sections were performed at 10μm resolution. Relative length was determined relative to wildtype controls.

Whole-mount *in situ* hybridization and skeletal preparations {#S9}
-------------------------------------------------------------

Whole-mount *in situ* hybridization was performed in wild type and mutant E13.5 embryos (n=4) according to standard procedures. All probes were generated by PCR amplification using mouse limb bud cDNA. For skeletal preparations, wildtype and mutant E17.5 embryos (n=4) were stained with Alcian Blue/Alizarin red according to standard protocols.

LacZ-staining {#S10}
-------------

E14.5 and E17.5 mouse embryos (n \> 5) were dissected in cold PBS, fixed in 4% PFA/PBS on ice for 30 min, washed twice with ice cold PBS and once at room temperature (19--24°C), and then stained overnight for β-galactosidase activity in a humid chamber at 37°C as previously described^[@R17]^. After staining, embryos were washed in PBS and stored at 4°C in 4% PFA/PBS.

Statistical analyses {#S11}
--------------------

Results are presented as the mean ± s.d. of at least 3 independent biological replicates (n≥3). Statistical differences between the means were examined by two-sided Student's t-test. \*P \< 0.05 was considered statistically significant. Prespecified effect size was not defined.
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![A cluster of enhancers interacts with the *Ihh* promoter during mouse development\
Above, close-up of the *Ihh* genomic region. Genes and their transcription start sites are indicated, exons are shown in black, introns in light grey. The position of the LacZ reporter insertion is indicated (SB). Black bars indicate the size and position of previously described human duplications^[@R1],[@R2]^ converted to the mouse genome. 4C-seq performed in E14.5 limbs using the *Ihh* promoter as viewpoint is shown below. Note increased interactions with intron 3 of the adjacent *Nhej1* gene (see also [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). CTCF ChIP-seq performed in E14.5 limbs is shown (ENCODE)^[@R3]^ and blue/red arrows indicate motif orientation. Additional tracks below show H3K4me1, H3K27ac, as well as conservation. This information was used to predict enhancers i1--i9, indicated by light blue and gray bars. Below, transgenic reporter assay (LacZ) of elements positive at E14.5 and E17.5 (marked in light blue; panel displays embryos and handplates at E14.5 and dorsal view of forelimbs and top view of skulls at E17.5). Regulatory activity of the region as indicated by the inserted LacZ reporter (SB, black outline) is shown on left. Lower panel shows scoring of each element for tissue-specificity. Elements negative at E14.5 but with positive staining at E17.5 are marked in gray and shown in [Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}. Scale=2000μm (embryos/skulls), 500μm (handplates) and 1000μm (forelimbs).](nihms896448f1){#F1}

![Deletions of regulatory elements reveal additive control of *Ihh* expression\
(**A**) Deletions generated by CRISVar^[@R21]^ at the locus. *Ihh* knockout is shown for comparison (stop signal). CTCF ChIP-seq performed in E14.5 limbs is shown (ENCODE)^[@R3]^ and blue/red arrows indicate motif orientation. Deleted chromosomal region is represented as dotted line. Note that Del (4--9) and Del(7--9) delete only 1 intronic CTCF site, maintaining another intact. (**B**) *In situ* hybridization shows *Ihh* expression in handplates (E13.5). Note expression in digit tips and condensing digits in wt and loss of expression in all deletions containing enhancer i5. Scale bar=200 μm (handplates). (**C**) Skeletal stainings of forelimbs, autopod and skull (E17.5). Mutants displaying abnormal phenotypes are indicated by asterisks. Both, Del(2--9) and Del(4--9) result in massive reduction of limb size and reduced ossification similar to *Ihh* ko, whereas Del(4--6) and Del(7--9) mice did not show noticeable limb abnormalities. All studied mutants displayed skull defects (delayed ossification), an effect less prominent in Del(7--9) mutants (arrowhead). Scale bars=2000μm (forelimbs), 500μm (autopods) and 1000μm (skulls). (**D**) *Ihh* qPCR analysis in E13.5 forelimb, E17.5 growth plate (elbow) and skull. Deletion of intron 3 of *Nhej1* encompassing enhancers i2--i9 resulted in almost complete loss of *Ihh* expression in all tissues, whereas smaller deletions reduce expression partially. Bars represent mean of *n* ≥ 3 different individuals (circles). \**P*\< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001; ns, not significant.](nihms896448f2){#F2}

![Duplications of enhancer elements result in *Ihh* over- and misexpression\
(**A**) Duplications generated by CRISVar^[@R21]^. Duplicated fragment shown in blue/pink. (**B**) Forelimb morphology (P7). Dup(int) and Dup(csp) mice (homozygous) are normal, but Dup(syn)/+ display 2/5 syndactyly. Skeletal stainings (right) show short and broad terminal phalanges in Dup(syn)/+ mice (arrow). Scale bars=1000μm (P7), 200μm (E17.5 handplates). (**C**) *In situ* hybridization shows increased and broadened expression of *Ihh* and downstream effectors *Ptch1* and *Gli1* \[Dup(csp) \< Dup(int) \< Dup(syn)\]. Expression domains in Dup(syn)/+ mice extend into distal interdigital space (arrows). Note increased *Ihh* expression in digit condensations in Dup(int) compared to Dup(syn)/+ (small arrow), also observed across entire handplate. Scale bars=200μm. (**D**) Apoptosis in interdigital space (red signal). Note lack of signal in distal region in Dup(syn)/+ mutants (arrow). Scale bars=200μm. (**E**) Hindlimb morphology of Dup(syn)/+ mice. Note preaxial polydactyly and syndactyly 2/5. *In* situ hybridization shows increased *Ihh* expression (arrows) in preaxial region (insets). Scale bars=1000μm (P7), 200μm (E12.5/E13.5). (**F**) *Ihh* qPCR analysis. Duplications increase *Ihh* expression. High levels in Dup(csp) forelimbs (no phenotype) result from digit condensations, while moderate upregulation in Dup(syn)/+ (syndactyly) derives from fingertips. Bars represent mean of *n* ≥ 3 different individuals (circles). \**P*\< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; ns, not significant. (**G**) μCT skull analysis (P70). Red square indicates enlargement of metopic suture region (right). Below, cross section of metopic sutures (red arrow). All mutants display complete suture fusion \[maximum effect in Dup(int)\]. Scale bars=2mm (skull), 1mm (enlargement), 0.5μm (cross section).](nihms896448f3){#F3}

![4C-seq reveals specific regulatory configurations in duplications\
(**A**) Schematic of wt locus. Continuous arrow indicates interaction between *Ihh* and enhancers i4--6, while discontinuous arrows indicate interaction of *Ihh* with i7--9. Below, CTCF ChIP-seq (E14.5 limbs, ENCODE)^[@R3]^. Blue/red arrows indicate motif orientation. 4C-seq (viewpoint=*Ihh* promoter) shows interaction profile in E14.5 handplates. A schematic of limb morphology is shown on right panel. (**B**) Duplication of intron 3 of *Nhej1* \[Dup(int)\] and re-engineered human duplication causing syndactyly \[Dup(syn)\] below. Duplicated regions are indicated by blue/pink. 4C-seq profile (viewpoint=*Ihh* promoter) and ratio to wt control are shown for each duplication. Brackets indicate regions with gain of interaction. Note no gain of interaction with the region containing enhancers i6--i9 (black dashed bracket) in Dup(syn)/+, indicating that the duplicated *Ihh* copy does not interact with this region. Observed phenotypes are schematically shown on right panel. Asterisk indicates increased interactions with *Cnppd1* and *Fam134a* genes, which does not have functional consequences (see [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). (**C**) Model of regulatory interactions of duplicated alleles. In Dup(int), *Ihh* can interact with the entire duplicated landscape, including two copies of the main digit enhancer (i5). In Dup(syn), both *Ihh* copies interact with a downstream copy of the i5 enhancer (large continuous arrows) but only the telomeric *Ihh* copy has access to i7--9 (discontinuous arrows) due to the presence of the divergent CTCF cluster (bracket). Additionally, the duplicated i5 enhancer interacts with the telomeric *Ihh* copy due to genomic proximity (short continuous arrow). Duplicated regions are indicated in blue/pink.](nihms896448f4){#F4}
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